The DSP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the DSP gene, which are associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 (ARVC8). ARVC8 is a form of heart disease that affects the muscle of the right ventricle, leading to arrhythmias and potentially heart failure. This genetic condition is inheritable, making the test particularly valuable for individuals with a family history of ARVC8 or related symptoms.
The test involves analyzing the patient's DNA to identify any genetic variations in the DSP gene that could indicate a predisposition to developing ARVC8. Early detection through this genetic test can be crucial for managing the condition, allowing for tailored treatment plans and lifestyle adjustments to mitigate the risk of severe cardiac events.
The cost of the DSP Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 8 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its potential to significantly impact patient care, the investment can be considered valuable for those at risk. DNA Labs UAE provides this testing service with professionalism and confidentiality, ensuring that patients receive accurate and helpful genetic insights into their cardiac health.
The PKP2 gene arrhythmogenic right ventricular cardiomyopathy type 9 genetic test is a specialized diagnostic tool designed to identify mutations in the PKP2 gene, which are linked to arrhythmogenic right ventricular cardiomyopathy (ARVC) type 9. ARVC is a form of heart disease that affects the muscle of the right ventricle, leading to arrhythmias and heart failure. The condition is genetic and can be passed down through families.
This specific test is crucial for individuals with a family history of ARVC or those showing symptoms of the condition, such as palpitations, fainting, or sudden cardiac arrest, as early detection can significantly influence management and treatment strategies. By analyzing the PKP2 gene, healthcare providers can confirm the diagnosis of ARVC type 9, assess the risk of developing the condition among family members, and implement preventative measures or treatments to mitigate heart damage and improve patient outcomes.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive information it provides to both patients and healthcare professionals. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, which is critical for managing a condition as serious as ARVC type 9.
The RYR2 gene arrhythmogenic right ventricular dysplasia type 2 genetic test is a specialized diagnostic tool designed to identify mutations in the RYR2 gene, which are associated with arrhythmogenic right ventricular dysplasia type 2 (ARVD2). ARVD2 is a rare form of cardiomyopathy that affects the muscle of the right ventricle of the heart, potentially leading to heart rhythm problems and heart failure. This condition is inheritable, making genetic testing crucial for families with a history of ARVD2 to identify at-risk individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the RYR2 gene to detect specific genetic alterations that contribute to the development of ARVD2. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations within the RYR2 gene.
By undergoing this test, individuals can gain valuable insights into their genetic predisposition to ARVD2, allowing for early intervention, personalized treatment plans, and informed family planning decisions. DNA Labs UAE provides a reliable and confidential service, ensuring that patients receive the support and information they need to navigate the complexities of genetic health.
The SCN5A Gene Atrial Fibrillation Type 10 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SCN5A gene that are associated with Atrial Fibrillation Type 10. Atrial Fibrillation (AF) is a common type of heart arrhythmia characterized by rapid and irregular heartbeats. Type 10 Atrial Fibrillation is specifically linked to genetic variations in the SCN5A gene, which plays a crucial role in the regulation of cardiac sodium channels. These channels are essential for the proper electrical signaling in the heart, and mutations can disrupt this process, leading to the development of arrhythmias.
This genetic test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the SCN5A gene. Identifying these mutations can be critical for understanding the genetic basis of the individual's atrial fibrillation, guiding treatment decisions, and assessing the risk of AF in family members.
The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the specific genetic variations. DNA Labs UAE, known for its state-of-the-art facilities and highly qualified staff, ensures a reliable and efficient testing process, providing patients and healthcare providers with essential information for managing and treating Atrial Fibrillation Type 10.
The GJA5 gene, associated with Atrial Fibrillation Type 11, plays a critical role in the proper electrical signaling and function of the heart. Mutations in the GJA5 gene can disrupt this process, leading to atrial fibrillation, a common type of heart rhythm disorder characterized by rapid and irregular beating of the atria. The condition can lead to various complications, including stroke and heart failure, making early detection and management crucial.
The GJA5 Gene Atrial Fibrillation Type 11 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GJA5 gene. This test is pivotal for individuals with a family history of atrial fibrillation or those exhibiting symptoms related to the condition, as it can provide a definitive diagnosis, enabling personalized treatment plans and management strategies to mitigate risks associated with the disorder.
The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and reliability, offering crucial insights into the genetic underpinnings of atrial fibrillation. This information is invaluable for affected individuals and their families, paving the way for informed healthcare decisions and potentially improving patient outcomes.
The ABCC9 Gene Atrial Fibrillation Type 12 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ABCC9 gene, which are associated with Atrial Fibrillation Type 12. This condition is a type of cardiac arrhythmia characterized by irregular heartbeats, which can lead to heart-related complications, stroke, and systemic embolism. The ABCC9 gene plays a crucial role in potassium ion transport across cell membranes, affecting heart muscle function and electrical activity. Mutations in this gene can disrupt normal heart rhythm, leading to the development of atrial fibrillation.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the ABCC9 gene. This test is essential for individuals with a family history of atrial fibrillation or those who exhibit symptoms related to abnormal heart rhythms, as it can provide a definitive diagnosis and guide treatment decisions. Early detection through this genetic test can significantly improve management strategies and outcomes for individuals with Atrial Fibrillation Type 12.
The "KCNQ1 Gene Atrial Fibrillation Type 3 Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the KCNQ1 gene, which have been associated with Atrial Fibrillation Type 3. Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by irregular heartbeat, which can lead to blood clots, stroke, heart failure, and other heart-related complications. Type 3 Atrial Fibrillation is a hereditary form of this condition, often linked to genetic mutations.
The KCNQ1 gene plays a crucial role in cardiac electrical activity, influencing the heart's rhythm and rate. Mutations in this gene can disrupt the normal heart rhythm, leading to the development of atrial fibrillation. Identifying these mutations is critical for early diagnosis, personalized treatment planning, and managing the risk of complications associated with atrial fibrillation.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 3200 AED. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of atrial fibrillation, enabling more targeted and effective management of the condition.
The KCNE2 Gene Atrial Fibrillation Type 4 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the KCNE2 gene, which are associated with the development of Type 4 Atrial Fibrillation. Atrial Fibrillation (AF) is a common type of heart arrhythmia characterized by rapid and irregular heartbeat, which can lead to blood clots, stroke, heart failure, and other heart-related complications. Type 4 Atrial Fibrillation is genetically inherited, making this test crucial for individuals with a family history of the condition, or those exhibiting symptoms, to understand their genetic predisposition.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. This sample is then analyzed in the laboratory to detect any genetic variations in the KCNE2 gene that may increase the risk of developing Atrial Fibrillation. The results from this test can provide valuable information for patients and their healthcare providers to devise personalized management and treatment plans, potentially including lifestyle changes, medication, or monitoring strategies to mitigate the risk of complications associated with Atrial Fibrillation.
DNA Labs UAE, known for its state-of-the-art genetic testing services, ensures a high level of accuracy and reliability in the test results, aiding in the early detection and proactive management of Type 4 Atrial Fibrillation.
The NPPA Gene Atrial Fibrillation Type 6 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect genetic mutations associated with Atrial Fibrillation Type 6. This condition is a subtype of atrial fibrillation, a common heart rhythm disorder characterized by rapid and irregular beating of the atria, the heart's upper chambers. The test specifically focuses on mutations in the NPPA gene, which encodes the atrial natriuretic peptide, a key regulator of blood pressure and fluid balance. Mutations in this gene can disrupt its normal function, leading to an increased risk of developing atrial fibrillation.
Administered at a cost of 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic anomalies in the NPPA gene. This genetic testing is crucial for individuals with a family history of atrial fibrillation or those who have been diagnosed with the condition but have an unknown cause, as it can provide valuable information for risk assessment, personalized treatment planning, and family counseling. DNA Labs UAE, with its state-of-the-art facilities and experienced professionals, ensures accurate and reliable testing results, contributing significantly to the management and understanding of atrial fibrillation.
The "KCNA5 Gene Atrial Fibrillation Type 7 Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the KCNA5 gene, which have been associated with Atrial Fibrillation Type 7. Atrial fibrillation (AF) is a common cardiac rhythm disorder characterized by rapid and irregular beating of the atria, the two upper chambers of the heart. Type 7 of this condition is genetically linked, specifically to mutations in the KCNA5 gene, which encodes for a potassium channel involved in the electrical activity of the heart. Identifying mutations in this gene can help in understanding the genetic basis of atrial fibrillation in affected individuals, potentially leading to personalized treatment plans and management strategies.
The test is offered at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis, including the use of sophisticated technology to accurately identify genetic variations associated with the condition. This test is particularly valuable for individuals with a family history of atrial fibrillation or those who have been diagnosed with the condition without an identifiable cause, as it provides critical insights into the genetic factors influencing the disorder.
